Variant report

Variant	nsv561392
Chromosome Location	chr13:30071245-30091819
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:27)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:9)

No data

(count:27 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr13:30091097..30092804-chr13:30167943..30169459,2	K562	blood:
2	chr13:30074865..30078261-chr13:30079505..30082420,3	K562	blood:
3	chr13:30080252..30082787-chr13:30168162..30169965,2	MCF-7	breast:
4	chr13:30074160..30075942-chr13:30076052..30078263,2	MCF-7	breast:
5	chr13:30074160..30075942-chr13:30076052..30078263,2	MCF-7	breast:
6	chr13:30046521..30047179-chr13:30082394..30082911,2	MCF-7	breast:
7	chr13:30081784..30083540-chr13:30281671..30282678,17	MCF-7	breast:
8	chr13:30087328..30089533-chr13:30164162..30166342,2	MCF-7	breast:
9	chr13:30070420..30074031-chr13:30074570..30077509,3	MCF-7	breast:
10	chr13:30082618..30084607-chr13:30095133..30096907,2	K562	blood:
11	chr13:30086955..30089041-chr13:30166781..30169428,2	MCF-7	breast:
12	chr13:30087488..30090042-chr13:30094216..30096567,2	MCF-7	breast:
13	chr13:30069723..30071518-chr13:30169502..30172461,2	MCF-7	breast:
14	chr13:30086595..30089289-chr13:30090102..30093020,2	K562	blood:
15	chr13:30081966..30082930-chr13:30281642..30282704,6	MCF-7	breast:
16	chr13:30090549..30093247-chr13:30094397..30096373,2	K562	blood:
17	chr13:30081296..30083385-chr13:30689063..30690673,2	MCF-7	breast:
18	chr13:30059938..30062417-chr13:30069208..30071863,2	MCF-7	breast:
19	chr13:30086595..30089289-chr13:30090102..30093020,2	K562	blood:
20	chr13:30076045..30078602-chr13:30271472..30273555,2	MCF-7	breast:
21	chr13:30074865..30078261-chr13:30079505..30082420,3	K562	blood:
22	chr13:30086183..30088447-chr13:30100578..30102906,2	K562	blood:
23	chr13:30082009..30082874-chr13:30281689..30282679,3	K562	blood:
24	chr13:30070422..30071147-chr13:30081856..30082468,2	MCF-7	breast:
25	chr13:30069216..30072289-chr13:30088515..30091504,3	MCF-7	breast:
26	chr13:30083698..30085805-chr13:30160713..30163555,2	MCF-7	breast:
27	chr13:30085195..30087223-chr13:30096814..30099566,2	MCF-7	breast:

No data

(count:9 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location
1	SLC7A1	hsa-miR-124-3p	chr13:30084034-30084053
2	MTUS2	hsa-miR-146a-5p	chr13:30077973-30077997
3	SLC7A1	hsa-miR-124-3p	chr13:30084040-30084034
4	MTUS2	hsa-miR-124-3p	chr13:30077788-30077808
5	SLC7A1	hsa-miR-16-5p	chr13:30087834-30087828
6	SLC7A1	hsa-miR-122-5p	chr13:30084506-30084499
7	SLC7A1	hsa-miR-16-5p	chr13:30087106-30087127
8	SLC7A1	hsa-miR-125b-5p	chr13:30084222-30084243
9	SLC7A1	hsa-miR-125b-5p	chr13:30084228-30084222

Variant related genes	Relation type
ENSG00000132938	chromatin interactions
ENSG00000139514	chromatin interactions
ENSG00000179141	chromatin interactions

Extended variants
information (count: 915 )
Associated
traits (count: 96 )

Variant overlapped rSNPs/rCNVs (count:915 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7329421	chr13:30071245-30071246	Enhancers Genic enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs71434730	chr13:30071265-30071266	Enhancers Genic enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs2258198	chr13:30071310-30071311	Enhancers Genic enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
4	rs554258914	chr13:30071312-30071313	Enhancers Genic enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs372097900	chr13:30071321-30071322	Enhancers Genic enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs573888663	chr13:30071340-30071341	Enhancers Genic enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs374826458	chr13:30071342-30071343	Enhancers Genic enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs367810786	chr13:30071389-30071390	Enhancers Genic enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs370672492	chr13:30071427-30071428	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs373897999	chr13:30071429-30071430	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs368057824	chr13:30071430-30071431	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs371880826	chr13:30071436-30071437	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs375267526	chr13:30071454-30071455	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs368605409	chr13:30071459-30071460	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs536439350	chr13:30071461-30071462	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs80220576	chr13:30071486-30071487	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs2297341	chr13:30071503-30071504	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs374695834	chr13:30071507-30071508	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs370126616	chr13:30071509-30071510	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs368909661	chr13:30071515-30071516	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs61946566	chr13:30071522-30071523	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs376392233	chr13:30071529-30071530	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs546172971	chr13:30071550-30071551	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs571919961	chr13:30071576-30071577	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs370038520	chr13:30071579-30071580	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs560609966	chr13:30071580-30071581	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs529486054	chr13:30071585-30071586	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs549162889	chr13:30071625-30071626	Enhancers Weak transcription Bivalent Enhancer Active TSS Strong transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs562877141	chr13:30071649-30071650	Enhancers Weak transcription Bivalent Enhancer Active TSS Strong transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs532047373	chr13:30071666-30071667	Enhancers Weak transcription Bivalent Enhancer Active TSS Strong transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs144676663	chr13:30071670-30071671	Enhancers Weak transcription Bivalent Enhancer Active TSS Strong transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs571617779	chr13:30071683-30071684	Enhancers Weak transcription Bivalent Enhancer Active TSS Strong transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs533898565	chr13:30071711-30071712	Enhancers Weak transcription Bivalent Enhancer Active TSS Strong transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs547949893	chr13:30071767-30071768	Enhancers Weak transcription Bivalent Enhancer Active TSS Strong transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs147902882	chr13:30071768-30071769	Enhancers Weak transcription Bivalent Enhancer Active TSS Strong transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs536476331	chr13:30071781-30071782	Enhancers Weak transcription Bivalent Enhancer Active TSS Strong transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs140513984	chr13:30071801-30071802	Weak transcription Enhancers Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs149979583	chr13:30071812-30071813	Weak transcription Enhancers Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs538948454	chr13:30071846-30071847	Weak transcription Enhancers Bivalent Enhancer Active TSS Strong transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs558527010	chr13:30071901-30071902	Weak transcription Enhancers Bivalent Enhancer Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs572018175	chr13:30071914-30071915	Weak transcription Enhancers Bivalent Enhancer Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs116041503	chr13:30071969-30071970	Weak transcription Enhancers Bivalent Enhancer Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs373881086	chr13:30071981-30071982	Weak transcription Enhancers Bivalent Enhancer Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs551446195	chr13:30072048-30072049	Weak transcription Enhancers Bivalent Enhancer Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs540197078	chr13:30072206-30072207	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs574179100	chr13:30072221-30072222	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs543078970	chr13:30072228-30072229	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs563118330	chr13:30072240-30072241	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs183657284	chr13:30072293-30072294	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs552059213	chr13:30072313-30072314	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:96)

Disease	PMID	Source
Cancer	20164920	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	18698080	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Squamous cell cancer	20885788	CNVD
Thyroid cancer	19087340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Malignant glioma	17146433	CNVD
Breast cancer	17899364	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	16774939	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	18179710	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Myelofibrosis	22110671	CNVD
Non-small cell lung cancer	21829676	CNVD
Retinoblastoma	22278416	CNVD
Peters Plus syndrome	16909395	CNVD
Trisomy	24170809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Breast cancer	20031965	CNVD
Colorectal cancer	19287155	CNVD
Ovarian cancer	19047089	CNVD
Alveolar rhabdomyosarcoma	16790082	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21364760	CNVD
Breast cancer	22522925	CNVD
Lung adenocarcinoma	21935476	CNVD
Autism	19492091	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Developmental delay	21147756	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Melanoma	20877625	CNVD

Chromatin state (count:728 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:30047200-30081000	Weak transcription	Pancreatic Islets	Pancreatic Islet
2	chr13:30062400-30087200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
3	chr13:30065000-30077200	Weak transcription	Fetal Brain Female	brain
4	chr13:30066400-30084400	Weak transcription	H9 Cell Line	embryonic stem cell
5	chr13:30068000-30071800	Enhancers	Primary B cells from peripheral blood	blood
6	chr13:30068200-30072600	Weak transcription	Aorta	Aorta
7	chr13:30068400-30071800	Enhancers	Primary monocytes fromperipheralblood	blood
8	chr13:30068400-30072000	Enhancers	Primary B cells from cord blood	blood
9	chr13:30069400-30071400	Enhancers	Primary neutrophils fromperipheralblood	blood
10	chr13:30069600-30072400	Enhancers	Fetal Heart	heart
11	chr13:30069800-30071400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
12	chr13:30070000-30071400	Enhancers	Primary hematopoietic stem cells	blood
13	chr13:30070200-30071400	Enhancers	Duodenum Mucosa	Duodenum
14	chr13:30070200-30071400	Enhancers	Esophagus	oesophagus
15	chr13:30070200-30071400	Enhancers	Lung	lung
16	chr13:30070200-30071400	Enhancers	Right Atrium	heart
17	chr13:30070200-30071400	Enhancers	Skeletal Muscle Female	skeletal muscle
18	chr13:30070200-30071600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr13:30070200-30071600	Enhancers	Right Ventricle	heart
20	chr13:30070200-30071600	Enhancers	Stomach Smooth Muscle	stomach
21	chr13:30070200-30071600	Enhancers	Spleen	Spleen
22	chr13:30070200-30071800	Enhancers	Brain Cingulate Gyrus	brain
23	chr13:30070200-30071800	Bivalent Enhancer	Placenta	Placenta
24	chr13:30070200-30072000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
25	chr13:30070200-30072000	Bivalent Enhancer	Adipose Nuclei	Adipose
26	chr13:30070200-30072200	Enhancers	Fetal Muscle Trunk	muscle
27	chr13:30070200-30072800	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
28	chr13:30070200-30072800	Enhancers	Ovary	ovary
29	chr13:30070200-30072800	Enhancers	Placenta Amnion	Placenta Amnion
30	chr13:30070200-30073200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
31	chr13:30070200-30075600	Enhancers	Fetal Stomach	stomach
32	chr13:30070400-30071600	Enhancers	Rectal Mucosa Donor 31	rectum
33	chr13:30070400-30071800	Enhancers	H1 Cell Line	embryonic stem cell
34	chr13:30070400-30071800	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
35	chr13:30070400-30071800	Enhancers	Brain Inferior Temporal Lobe	brain
36	chr13:30070400-30071800	Enhancers	Fetal Lung	lung
37	chr13:30070400-30072000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
38	chr13:30070400-30073000	Enhancers	HSMMtube	muscle
39	chr13:30070600-30071600	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
40	chr13:30070600-30071800	Enhancers	Brain Hippocampus Middle	brain
41	chr13:30070600-30072000	Enhancers	Cortex derived primary cultured neurospheres	brain
42	chr13:30070600-30072400	Enhancers	Primary hematopoietic stem cells short term culture	blood
43	chr13:30070600-30072600	Enhancers	Fetal Muscle Leg	muscle
44	chr13:30070600-30077200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
45	chr13:30070600-30077200	Weak transcription	Brain Anterior Caudate	brain
46	chr13:30070800-30071400	Weak transcription	Brain Germinal Matrix	brain
47	chr13:30070800-30071600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
48	chr13:30070800-30071800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
49	chr13:30070800-30071800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
50	chr13:30070800-30071800	Bivalent Enhancer	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links